Montana Molecular LLC

Bozeman, MT

UEI
KN3BF8Y27ES3
CAGE
474Z3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
366 Gallatin Park Dr a, Bozeman, MT 59715, USA
Website
montanamolecular.com
Founded
2007
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

SBA capabilities narrative

Montana Molecular develops fluorescent biosensors and live cell assays for basic research and drug discovery. The company provides custom BacMam vectors and live cell assay optimization services for life science research.

Quick answers

What is Montana Molecular LLC's UEI?

Montana Molecular LLC's Unique Entity ID (UEI) in SAM.gov is KN3BF8Y27ES3.

What is Montana Molecular LLC's CAGE code?

Montana Molecular LLC's CAGE code is 474Z3.

What is Montana Molecular LLC's primary NAICS code?

Montana Molecular LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Montana Molecular LLC located?

Montana Molecular LLC's physical address in SAM.gov is 366 Gallatin Park Dr a, Bozeman, MT 59715, USA.

Is Montana Molecular LLC registered in SAM.gov?

Yes. Montana Molecular LLC's SAM.gov registration is active through February 21, 2027.

What is Montana Molecular LLC's most recent federal award?

Montana Molecular LLC's most recent federal grant award is Fluorescent biosensors for measuring the signaling kinetics of gpcr ligands that activate G12/13 pathways. - abstract… (R43CA295295), from National Cancer Institute, on September 1, 2025.

On GovTribe

See Montana Molecular LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors